Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
QuintilesIMS
Accenture
UBS
Citi
Cipla
Express Scripts
Harvard Business School
Medtronic

Generated: February 25, 2018

DrugPatentWatch Database Preview

Valproic acid - Generic Drug Details

« Back to Dashboard

What are the generic sources for valproic acid and what is the scope of valproic acid patent protection?

Valproic acid
is the generic ingredient in three branded drugs marketed by Bionpharma Inc, Abbvie, Catalent, Par Pharm, Scherer Rp, Sun Pharm Inds Ltd, Usl Pharma, Ani Pharms Inc, Apotex Inc, Eci Pharms Llc, High Tech Pharma, Pharm Assoc, Vintage, Vistapharm, and Wockhardt Bio Ag, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for valproic acid. Twenty-three suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for valproic acid

US Patents and Regulatory Information for valproic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie DEPAKENE valproic acid SYRUP;ORAL 018082-001 Approved Prior to Jan 1, 1982 AA RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Scherer Rp VALPROIC ACID valproic acid CAPSULE;ORAL 070195-001 Jul 2, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vistapharm VALPROIC ACID valproic acid SYRUP;ORAL 075782-001 Dec 22, 2000 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharm Assoc VALPROIC ACID valproic acid SYRUP;ORAL 075379-001 Dec 15, 2000 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc VALPROIC ACID valproic acid SYRUP;ORAL 073178-001 Aug 25, 1992 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc VALPROIC ACID valproic acid SYRUP;ORAL 077105-001 Jul 29, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Catalent VALPROIC ACID valproic acid CAPSULE;ORAL 073229-001 Oct 29, 1991 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bionpharma Inc STAVZOR valproic acid CAPSULE, DELAYED RELEASE;ORAL 022152-003 Jul 29, 2008 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie DEPAKENE valproic acid CAPSULE;ORAL 018081-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd VALPROIC ACID valproic acid CAPSULE;ORAL 091037-001 Feb 22, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
Merck
Healthtrust
QuintilesIMS
US Department of Justice
Chinese Patent Office
Cipla
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot